Jeremy B. Hayden sold $25k of SGHT
Chief Legal Officer at Sight Sciences, Inc.. 3,150 shares at an average of $8.01, traded Nov 12, 2025, filed Nov 14, 2025.
Score components
- +15RoleOfficer
- +5Trade size$25k at market
- 0Share of holdings soldSold 1.2% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +13.9%, 3m -24.6%, 6m -30.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-283548, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | MOption exercise Common Stock10b5-1 | +2,440 | $1.96 | $4,782 | 259,030 | Nov 14, 2025 |
| Nov 12, 2025 | MOption exercise Common Stock10b5-1 | +710 | $1.96 | $1,392 | 259,740 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale Common Stock10b5-1 | -3,150 | $8.01 | $25k | 256,590 | Nov 14, 2025 |
| Nov 12, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,440 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Nov 12, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -710 | $0.00 | $0 | 0 | Nov 14, 2025 |
Related signals
Other insiders at Sight Sciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $71k 7,797 shares | -0% | |
| 33Weak | Sight Sciences, Inc. | Paul Badawi President and CEO | $268k 29,653 shares | -0% | |
| 27Weak | Sight Sciences, Inc. | Alison Bauerlein Chief Operating Officer | $224k 25,260 shares | -4% | |
| 25Weak | Sight Sciences, Inc. | James Rodberg Chief Financial Officer | $64k 7,208 shares | -3% | |
| 15Weak | Sight Sciences, Inc. | Brenton Taylor EVP, Operations & R&D | $26k 2,988 shares | -1% | |
| 16Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $41k 7,418 shares | -0% | |
| 31Weak | Sight Sciences, Inc. | Paul Badawi President and CEO | $155k 28,684 shares | -0% | |
| 26Weak | Sight Sciences, Inc. | Alison Bauerlein Chief Operating Officer | $130k 24,184 shares | -4% | |
| 18Weak | Sight Sciences, Inc. | Jeremy B. Hayden Chief Legal Officer | $70k 12,733 shares | -3% | |
| 23Weak | Sight Sciences, Inc. | James Rodberg Chief Financial Officer | $37k 6,902 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.